Sign In
test

Hongbo Bao

Decheng Capital Llc

Assets Managed
$661.316M
Holdings
14
Last Quarter
2026 - Q1
Filed Date
1mo 7d ago
Growth Rate
-11.04%(2Q avg: 9.33%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Decheng Capital Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 14 positions.

Assets under management

The assets under management (AUM) of Decheng Capital Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 661.316M in assets, with a quarterly growth rate of -11.04% and a 2-quarter average growth rate of 9.33%. The portfolio is managed by Hongbo Bao, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
CGON
Cg Oncology Inc
Recent Activity
65.21%
$431.235M
6.372M shares@ $67.69 avg price
NUVB
Nuvation Bio Inc
Recent Activity
16.84%
$111.345M
25.954M shares@ $4.29 avg price
UPB
Upstream Bio Inc
Recent Activity
Decreased -13.3%
3.71%
$24.524M
2.725M shares@ $9.0 avg price
ACRS
Aclaris Therapeutics Inc
Recent Activity
2.3%
$15.157M
4.042M shares@ $3.75 avg price
AARD
Aardvark Therapeutics Inc
Recent Activity
2.24%
$14.768M
3.917M shares@ $3.77 avg price
LYEL
Lyell Immunopharma Inc
Recent Activity
2.1%
$13.883M
692,050 shares@ $20.06 avg price
NAMS
Newamsterdam Pharma Co Nv
Recent Activity
Decreased -45.09%
1.58%
$10.405M
325,057 shares@ $32.02 avg price
RCUS
Arcus Biosciences Inc
Recent Activity
Decreased -11.76%
1.57%
$10.321M
477,819 shares@ $21.6 avg price
RVMD
Revolution Medicines Inc
Recent Activity
Decreased -53.25%
1.38%
$9.093M
93,500 shares@ $97.25 avg price
EQ
Equillium Inc
Recent Activity
1.35%
$8.895M
4.447M shares@ $2.0 avg price

1-10 of 14